The results of screening trials are used to inform clinical guidelines and public health policies. For example, the U.S. Preventive Services Task Force (USPSTF) evaluates evidence from screening trials to make recommendations about which screening tests should be routinely used. These guidelines help healthcare providers and patients make informed decisions about cancer screening.
